Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative dexmedetomidine nasal spray in thoracoscopic surgery
ChiCTR2400091847Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoints: Sedation scores (sedation success rate), Anxiety scores and 1 more. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on ChiCTR2400091847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091847.